Common Contracts
3 similar null contracts by Fossil Inc, Serologicals Corp, TNS Inc
SEROLOGICALS CORPORATION 5,562,860 Shares of Common Stock Underwriting AgreementSerologicals Corp • December 17th, 2004 • Biological products, (no disgnostic substances) • New York
Serologicals Corporation, a Delaware corporation (the "Company"), proposes to issue and sell to the several Underwriters listed in Schedule I hereto (the "Underwriters"), for whom you are acting as representative (the "Representative"), an aggregate of 4,200,000 shares of Common Stock, par value $0.01 per share, of the Company and, at the option of the Underwriters, up to an additional 630,000 shares of Common Stock, solely to cover over-allotments. In addition, the stockholders named in Schedule II hereto (the "Selling Stockholders") propose to sell to the Underwriters an aggregate of 1,362,860 shares of Common Stock. The aggregate of 5,562,860 shares to be sold by the Company and the Selling Stockholders is herein called the "Underwritten Shares" and the aggregate of 630,000 additional shares that may be sold by the Company to cover over-allotments is herein called the "Option Shares". The Underwritten Shares and the Option Shares are herein referred to as the "Shares". The shares of
LEHMAN BROTHERS INC. J.P. MORGAN SECURITIES INC. FORM OF UNDERWRITING AGREEMENT TNS, INC. 5,815,203 Shares of Common StockTNS Inc • September 9th, 2004 • Services-business services, nec • New York
Lehman Brothers Inc. J.P. Morgan Securities Inc. As Representatives of the several Underwriters listed in Schedule I hereto c/o Lehman Brothers Inc. 745 Seventh Avenue New York, New York 10019
FOSSIL, INC. 6,525,000 Shares of Common Stock, $.01 par value Underwriting AgreementFossil Inc • May 12th, 2004 • Watches, clocks, clockwork operated devices/parts • New York
Certain stockholders of Fossil, Inc., a Delaware corporation (the "Company"), named in Schedule II hereto (the "Selling Stockholders") propose to sell to the several Underwriters listed in Schedule I hereto (the "Underwriters"), for whom you are acting as representatives (the "Representatives"), an aggregate of 6,525,000 shares of common stock, par value $.01 per share (the "Underwritten Shares"), of the Company. The Selling Stockholders also propose to grant to the Underwriters an option to purchase up to 978,750 additional shares of common stock of the Company (the "Option Shares"). The Underwritten Shares and the Option Shares are herein referred to as the "Shares". The outstanding shares of common stock, par value $.01 per share of the Company are herein referred to as the "Stock". Unless otherwise noted herein, all references to "subsidiaries" includes Fossil Partners, L.P.
